All Stories

  1. Accessibility of Ontario pharmacies offering COVID-19 vaccination by rurality, community material deprivation, and ethnic concentration: a repeated cross-sectional geospatial analysis

    Article • BMC Public Health, November 2025, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  2. Healthcare costs and cost determinants of minor ailments: A population-based retrospective cohort study

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Dr. Wasem Alsabbagh

  3. Fostering career-readiness in pharmacy students through work-integrated learning: Qualitative analysis of co-op supervisor and rotation preceptor feedback on student performance

    Article • Currents in Pharmacy Teaching and Learning, October 2025, Elsevier

    Dr. Wasem Alsabbagh

  4. Income-Based Disparities in Opioid Prescription Dispensing Among Public Drug Plan Beneficiaries in Canada from 2010 to 2018: A Population-Based and Sex-Stratified Retrospective Study

    Article • Drugs - Real World Outcomes, May 2025, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  5. Validation of influenza vaccination status using health administrative databases by integrating pharmacy claims and medical billing databases in Ontario, Canada

    Article • BMC Infectious Diseases, May 2025, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  6. Accessibility of Ontario pharmacies offering COVID-19 vaccination by rurality, community material deprivation, and ethnic concentration : A repeated cross-sectional geospatial analysis

    Article • June 2024, Research Square

    Dr. Wasem Alsabbagh

  7. Association Between Opioid-Related Mortality and History of Surgical Procedure: A Population-Based Case-Control Study

    Article • Annals of Surgery Open, April 2024, Wolters Kluwer Health

    Dr. Wasem Alsabbagh

  8. Health utilities in adults with hemophilia A: A retrospective cohort study

    Article • Haemophilia, March 2024, Wiley

    Dr. Wasem Alsabbagh

  9. Association between Pharmacists’ Country of Qualifying Education and Practising in a Hospital Setting: A Cross-Sectional Ontario Study

    Article • The Canadian Journal of Hospital Pharmacy, October 2023, Canadian Society of Hospital Pharmacists (CSHP)

    Dr. Wasem Alsabbagh

  10. Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom

    Article • Diabetes Obesity and Metabolism, August 2023, Wiley

    Dr. Wasem Alsabbagh, Dr. JM Gamble

  11. Herpes zoster and human papillomavirus vaccination opportunities identified using electronic prompts at the time of scheduling influenza or COVID-19 vaccines

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, July 2023, SAGE Publications

    Dr. Wasem Alsabbagh

  12. Évolution et déterminants de la vaccination contre la grippe saisonnière après une maladie cardiovasculaire au Canada : étude transversale pancanadienne répétée

    Article • Promotion de la santé et prévention des maladies chroniques au Canada, February 2023, Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada

    Dr. Wasem Alsabbagh

  13. The trends and determinants of seasonal influenza vaccination after cardiovascular events in Canada: a repeated, pan-Canadian, cross-sectional study

    Article • Health Promotion and Chronic Disease Prevention in Canada, February 2023, Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada

    Dr. Wasem Alsabbagh

  14. Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario

    Article • PharmacoEconomics, January 2023, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  15. Stepping up to the Canadian opioid crisis: a longitudinal analysis of the correlation between socioeconomic status and population rates of opioid-related mortality, hospitalization and emergency department visits (2000–2017)

    Article • Health Promotion and Chronic Disease Prevention in Canada, June 2022, Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada

    Dr. Wasem Alsabbagh

  16. Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus

    Article • Diabetic Medicine, May 2022, Wiley

    Dr. JM Gamble, Dr. Wasem Alsabbagh

  17. The association between the rate of potentially pharmacist-manageable emergency department visits and community income level and primary care provider availability: A spatial analysis

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, March 2022, SAGE Publications

    Dr. Wasem Alsabbagh

  18. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs

    Article • Diabetes & Metabolism, March 2022, Elsevier

    Dr. Wasem Alsabbagh, Dr. JM Gamble

  19. National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study

    Article • Addiction, January 2022, Wiley

    Dr. Wasem Alsabbagh

  20. Sodium-glucose cotransporter-2 inhibitors and urinary tract infections: A propensity score matched population-based cohort study.

    Article • Canadian Journal of Diabetes, December 2021, Elsevier

    Dr. Wasem Alsabbagh, Dr. JM Gamble

  21. Trends and Determinants of Self-Reported Aspirin Use among Patients with Diabetes Stratified by the Presence and Risk of Cardiovascular Diseases - Repeated Pan-Canadian Cross-Sectional Study

    Article • Canadian Journal of Diabetes, December 2021, Elsevier

    Dr. Wasem Alsabbagh, Dr. JM Gamble

  22. Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study

    Article • BMJ Open Diabetes Research & Care, December 2021, BMJ

    Dr. JM Gamble, Dr. Wasem Alsabbagh

  23. National trends in population rates of opioid‐related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population‐based study

    Article • Addiction, June 2021, Wiley

    Dr. Wasem Alsabbagh

  24. Economic evaluation of pharmacists prescribing for minor ailments in Ontario, Canada: a cost-minimization analysis

    Article • International Journal of Pharmacy Practice, March 2021, Oxford University Press (OUP)

    Dr. Wasem Alsabbagh

  25. The Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus

    Article • Healthcare Policy | Politiques de Santé, November 2020, Longwoods Publishing

    Dr. Wasem Alsabbagh

  26. Development of comparable algorithms to measure primary care indicators using administrative health data across three Canadian provinces

    Article • International Journal for Population Data Science, August 2020, Swansea University

    Dr. Wasem Alsabbagh

  27. Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias – A narrative review

    Article • Pharmacology Research & Perspectives, July 2020, Wiley

    Dr. Wasem Alsabbagh

  28. Estimates of population‐based incidence of malignant arrhythmias associated with medication use—a narrative review

    Article • Fundamental and Clinical Pharmacology, July 2020, Wiley

    Dr. Wasem Alsabbagh

  29. The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study

    Article • Research in Social and Administrative Pharmacy, January 2020, Elsevier

    Dr. Wasem Alsabbagh

  30. Achieving cross provincial comparisons of osteoporosis screening performance from administrative health data.

    Article • International Journal for Population Data Science, December 2019, Swansea University

    Dr. Wasem Alsabbagh

  31. Cost-Effectiveness of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B in Canada

    Article • PharmacoEconomics, November 2019, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  32. The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with expanded scope of practice

    Article • Research in Social and Administrative Pharmacy, November 2019, Elsevier

    Dr. Wasem Alsabbagh

  33. 128 - Trend and Determinants of Cholesterol-Lowering Medication Use Among Patients With Diabetes Mellitus in Canada: A Repeated Cross-Sectional Study

    Article • Canadian Journal of Diabetes, October 2019, Elsevier

    Dr. Wasem Alsabbagh

  34. Pharmacy patron perspectives of community pharmacist administered influenza vaccinations

    Article • Research in Social and Administrative Pharmacy, February 2019, Elsevier

    Dr. Wasem Alsabbagh

  35. Capsule Commentary on Goto et al.’s Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD

    Article • Journal of General Internal Medicine, July 2018, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  36. Pharmacists as immunizers, their pharmacies and immunization services: A survey of Ontario community pharmacists

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, June 2018, SAGE Publications

    Dr. Wasem Alsabbagh

  37. Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada

    Article • Canadian Journal of Diabetes, February 2018, Elsevier

    Dr. Wasem Alsabbagh

  38. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines

    Article • Research in Social and Administrative Pharmacy, January 2018, Elsevier

    Dr. Wasem Alsabbagh

  39. Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study

    Article • BMC Medical Research Methodology, April 2017, Springer Science + Business Media

    Dr. Wasem Alsabbagh

  40. Managing medications during Ramadan fasting

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, April 2017, SAGE Publications

    Kelly Grindrod, Dr. Wasem Alsabbagh

  41. Protecting our patients by protecting ourselves

    Article • Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, May 2016, SAGE Publications

    Nancy Waite, Dr. Wasem Alsabbagh

  42. Multiple-domain Versus Single-domain Measurements of Socioeconomic Status (SES) for Predicting Nonadherence to Statin Medications

    Article • Medical Care, February 2016, Wolters Kluwer Health

    Dr. Wasem Alsabbagh

  43. Abstract 19486: Does the Association Between Adherence to Statin Medications and Mortality Depend on the Measurement Approach? A Retrospective Cohort Study

    Article • Circulation, November 2015, Wolters Kluwer Health

    Dr. Wasem Alsabbagh

  44. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis

    Article • Clinical Journal of the American Society of Nephrology, July 2015, American Society of Nephrology

    Dr Salah Mahmud, Dr. Wasem Alsabbagh

  45. Trends in Prevalence, Incidence and Pharmacologic Management of Diabetes Mellitus Among Seniors Newly Admitted to Long-Term Care Facilities in Saskatchewan between 2003 and 2011

    Article • Canadian Journal of Diabetes, April 2015, Elsevier

    Dr. Wasem Alsabbagh

  46. Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis

    Article • Value in Health, March 2014, Elsevier

    Dr. Wasem Alsabbagh

  47. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis

    Article • Patient Preference and Adherence, February 2014, Taylor & Francis

    Dr. Wasem Alsabbagh

  48. Use and Misuse of Ezetimibe: Analysis of Use and Cost in Saskatchewan, a Canadian Jurisdiction With Broad Access

    Article • Canadian Journal of Cardiology, February 2014, Elsevier

    Dr. Wasem Alsabbagh

  49. Neighbourhood Income and Cardiac Rehabilitation Access as Determinants of Nonattendance and Noncompletion

    Article • Canadian Journal of Cardiology, December 2013, Elsevier

    Dr. Wasem Alsabbagh

  50. Pharmacologic Management of Diabetes among Seniors Newly Admitted to Long-term Care Facilities in Saskatchewan

    Article • Canadian Journal of Diabetes, October 2013, Elsevier

    Dr. Wasem Alsabbagh

  51. Incidence and Prevalence of Diabetes in Residents of Saskatchewan Long-Term Care Facilities between 2003 and 2011

    Article • Canadian Journal of Diabetes, October 2013, Elsevier

    Dr. Wasem Alsabbagh

  52. Pharmacist Intervention in Cardiac Rehabilitation

    Article • Journal of Cardiopulmonary Rehabilitation and Prevention, November 2012, Wolters Kluwer Health

    Dr. Wasem Alsabbagh